Curcumin-Induced Apoptosis of A-431 Cells Involves Caspase-3 Activation

Journal of Biochemistry and Molecular Biology

Volumn 34, Issue 3, 2001, Pages 189-193

  Shim, Joong Sup ^a   Lee, Hyung Joo ^a   Park, Sang Shin ^a   Cha, Bong Gee ^b   Chang, Hae Ryong ^a  

^a Dongguk University   (South Korea)

^b Dong san Herb Clinic   (South Korea)

Author keywords

Apoptosis; Caspase 3; Curcumin; DEVD CHO; Nitric oxides

Indexed keywords

EID: 0035592903     PISSN: 12258687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Abe, J. I. and Berk, B. C. (1999) Fyn and JAK2 mediate Ras activation by reactive oxygen species. J. Biol. Chem. 274(30), 21003-21010.
2. Bae, Y. S., Kang, S. W., Seo, M. S., Baines, I. C., Tekle, E., Chock, B. and Rhee, S. G. (1997) Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. J. Biol. Chem. 272(1), 217-221.
3. Chan, M. M., Huang, H. I., Fenton, M. R. and Fong, D. (1998) In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with antiinflammatory properties. Biochem. Pharmacol. 55(12), 1955-1962.
4. Chen, Y. R. and Tan, T. H. (1998) Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 17, 173-178.
5. Huang, M. T., Smart, R. C., Wong, C. Q. and Conney, A. H. (1988) Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 48(21), 5941-5946.
6. Huang, T. S., Lee, S. C. and Lin, J. K. (1991) Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA 88, 5292-5296.
7. Jaruga, E., Sokal, A., Chrul, S. and Bartosz, G. (1998) Apoptosis-independent alterations in membrane dynamics induced by curcumin. Exp. Cell Res. 245(2), 303-312.
8. Jeon, H., Kim, S. S., Kim, Y. S., Park, I. S., Kim, Y. H., Choi, S. J., Kim, S. K. and Kim, T. U. (1998) Cytotoxic and apoptotic activities of echinomycin derivative (echinomycin-7) on P388 murine leukemia cells. J. Biochem. Mol. Biol. 31, 560-564.
9. Jiang, S., Cai, J., Wallace, D. C. and Jones, D. P. (1999) Cytochrome c-mediated apoptosis in cells lacking mitochondrial DNA. J. Biol. Chem. 274(42), 29905-29911.
10. Khar, A, Ali, A. M., Pardhasaradhi, B. V. V., Begum, Z. and Anjum, R. (1999) Antitumor activity of curcumin is mediated through the induction of apoptosis in AK-5 tumor cells. FEBS Lett. 445, 165-168.
11. Kim, S. S., Kim, Y. S., Jung, Y. W., Choi, H. I., Shim, M. J. and Kim, T. U. (1999) Taxol-induced apoptosis and nuclear translocation of mitogen-activated protein (MAP) kinase in HeLa cells. J. Biochem. Mol. Biol. 32(4), 379-384.
12. Kim, T. U., Yang, S. H. and Kim, S. K. (1996) Cytotoxic and apoptotic effects of echinomycin on murine leukemia cells. J. Biochem. Mol. Biol. 29, 489-492.
13. Korutla, L., Cheung, J. Y., Mendelsohn, J. and Kumar, R. (1995) Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis 16(8), 1741-1745.
14. Korutla, L. and Kumar, R. (1994) Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A-431 cells. Biochim. Biophys. Acta 1224, 597-600.
15. Kuo, M. L., Hwang, T. S. and Lin, J. K. (1996) Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim. Biophys. Acta 1317, 95-100.
16. Kuttan, R., Bhanumathy, P., Nirmala, K. and George, M. C. (1985) Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett. 29(2), 197-202.
17. Lee, S., Park, S., Jun, G., Hahm, E. R., Lee, D. K. and Yang, C. H. (1999) Quantitative assay for the binding of Jun-Fos dimer and activator protein-1 site. J. Biochem. Mol. Biol. 32(6), 594-598.
18. Lee, E. Y., Park, K. K., Lee, J. M., Chun, K. S., Kang, J. Y., Lee, S. S. and Surh, Y. J. (1998) Suppression of mouse skin tumor promotion and induction of apoptosis in HL-60 cells by Alpinia oxyphylla Miquel (Zingiberaceae). Carcinogenesis 19(8), 1377-1381.
19. Liu, J. Y, Lin, S. J and Lin, J. K. (1993) Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis 14(5), 857-861.
20. Lo, Y. Y. C. and Cruz, T. F. (1995) Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J. Biol. Chem. 271(26), 15703-15707.
21. Lo, Y. Y. C., Wong, J. M. S. and Cruz, T. F. (1996) Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J. Biol. Chem. 271(26), 15703-15707.
22. Mannick, J. B., Hausladen, A., Liu, L., Hess, D. T., Zeng, M. Miao, Q. X., Kane, L. S., Gow, A. J. and Stamler, J. S. (1999) Fas-induced caspase denitrosylation. Science 284, 651-654.
23. Mehta, K., Pantazis, P., McQueen, T. and Aggarwal, B. B. (1997) Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs 8(5), 470-481.
24. Plumb, J. A., Milroy, R. and Kaye, S. B. (1989) Effects of the pH dependence of 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res. 49, 4435-4440.
25. Rao, C. V., Simi, B. and Reddy, B. S. (1993) Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis 14(11), 2219-2225.
26. Rao, C. V., Kawamori, T., Hamid, R. and Reddy, B. S. (1999) Chemopreventation of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis 20(4), 641-644.
27. Singh, S. and Aggarwal, B. B. (1995) Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane). J. Biol. Chem. 270(42), 24995-25000.
28. Toda, S., Miyase, T., Arichi, H., Tanizawa, H. and Takino, Y. (1985) Natural antioxidants. III. antioxidative components isolated from rhizome of Curcuma longa L. Chem. Pharm. Bull. 33(4), 1725-1728.